Taken together, these results demonstrated that BA inhibited MAPK/ERK signalling, thereby lowering UBE2T levels, preventing FA pathway activation, and ultimately enhancing the cytotoxic response of glioma tumours to cisplatin in vivo (Figure 6). Here, UBE2T is linked to glioma.